Publikacje

ZESPÓŁ  PUBLIKACJE  PROJEKTY   KONTAKT I WSPÓŁPRACA  PRACOWNIA

Selected publications:

2025:

• Zdanowicz A, Ilchenko O, Ciechanowicz A, Chi H, Struga M, Pyrzynska B. Low-Dose Salinomycin Alters Mitochondrial Function and Reprograms Global Metabolism in Burkitt Lymphoma. Int J Mol Sci 2025, 26(11):5125, https://doi.org/10.3390/ijms26115125
• Torun A, Zdanowicz A, Miazek-Zapala N, Zapala P, Pradhan B,…, Zerrouqi A, Pyrzynska B. Potassium/sodium cation carriers robustly up-regulate CD20 antigen by targeting MYC, and synergize with anti-CD20 immunotherapies to eliminate malignant B cells. Haematologica 2025, 110(7):1555, https://doi.org/10.3324/haematol.2024.285826

2024:

• Kaboli PJ, Roozitalab G, Farghadani R, Eskandarian Z, Zerrouqi A. c-MET and the Immuno-logical Landscape of Cancer: Novel Therapeutic Strategies for Enhanced Anti-Tumor Immunity. Front Immunol 2024,15:1498391,https://doi.org/10.3389/fimmu.2024.1498391
• Wlodarczyk M, Torun A, Zerrouqi A, Pyrzynska B. NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells. Int J Mol Sci 2024, 25(16):8980, https://doi.org/10.3390/ijms25168980
• Lica JJ, Pradhan B, Safi K, Jakóbkiewicz-Banecka J, Hellmann A. Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential. Molecules 2024, 29(17):4280, https://doi.org/10.3390/molecules29174280

2023:

• Wlodarczyk M, Pyrzynska B. CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer. Cancers 2023, 15(1):117, https://doi.org/10.3390/cancers15010117

2022:

• Ramji K, Grzywa TM, Sosnowska A, Paterek A, Okninska M, Pilch Z, Barankiewicz J, Garbicz F, Borg K, Bany-Laszewicz U, Zerrouqi A, Pyrzynska B, et al. Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity. Scientific Reports 2022, 12(1):19660, doi: 10.1038/s41598-022-24137-1

2021:

• 8. Szydłowski M, Garbicz F, Jabłońska E, Górniak P, Komar D, Pyrzyńska B, et al. Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies. Cancer Res 2021, 81(23):6029, https://doi.org/10.1158/0008-5472.CAN-21-1023
• 9. Torun A, Hupalowska A, Trzonkowski P, Kierkus J, Pyrzynska B. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children. Front Immunol 2021, 12:642166, doi: 10.3389/fimmu.2021.642166

2020:

• Lee SH, Khwaja Rehman F, Tyler KC, Yu B, Zhang Z, Osuka S, Zerrouqi A, Kaluzova M, Hadjipanayis CG, Cummings RD, Olson JJ, Devi NS, Van Meir EG. A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis. Clin Cancer Res 2020, 26(11):2711, https://doi.org/10.1158/1078-0432.CCR-18-3280

2019:

• Sasi BK, Martines C, Xerxa E, Porro F, Kalkan H, Fazio R, Turkalj S, Bojnik E, Pyrzynska B, Stachura J, Zerrouqi A, et al. Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma. Leukemia 2019, 33:2416, doi: 10.1038/s41375-019-0442-8
• Czystowska-Kuzmicz M, Sosnowska A, Nowis D, Ramji K, Szajnik M, Chlebowska-Tuz J, Wolinska E, Gaj P, Grazul M, Pilch Z, Zerrouqi A, et al. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nature Commun 2019, 10(1):3000, doi: 10.1038/s41467-019-10979-3
• Banach-Orlowska M, Wyszynska R, Pyrzynska B, Maksymowicz M, Golab J, Miaczynska M: Cholesterol restricts lymphotoxin beta receptor-triggered NF-kappaB signaling. Cell Commun Signal 2019, 17:171, doi: 10.1186/s12964-019-0460-1

2018:

• Pyrzynska B, Dwojak M, Zerrouqi A, Morlino G, Zapala P, Miazek N, Zagozdzon A, Bojarczuk K, Bobrowicz M, Siernicka M, et al. FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. Oncoimmunology 2018, 7:e1423183, https://doi.org/10.1080/2162402X.2017.1423183

• Bobrowicz M, Dwojak M, Pyrzynska B, …Zerrouqi A, Golab J, Winiarska M. HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies. Blood 2017, 130:1628, https://doi.org/10.1182/blood-2016-08-736066
• Slabicki M, Lee KS, Jethwa A, Sellner L, Sacco F, Walther T, Hullein J, Dietrich S, Wu B, Lipka DB, Oakes CC, Mamidi S, Pyrzyńska B, et al. Dissection of CD20 regulation in lymphoma using RNAi. Leukemia 2016, 30:2409, doi: 10.1038/leu.2016.230
• Zerrouqi A, Pyrzynska B, Brat DJ, Van Meir EG. P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway. Cancer Res. 2014 Mar 1;74(5):1371-8. doi: 10.1158/0008-5472.CAN-13-1951.
• Zerrouqi A, Pyrzynska B, Febbraio M, Brat DJ, Van Meir EG. P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3. J Clin Invest. 2012 Apr;122(4):1283-95. doi: 10.1172/JCI38596.